« Previous
Next »
Experimental Hematology
Volume 30, Issue 10
, Pages 1115-1123
, October 2002
Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion
References
- Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J. 1986;5:871
- Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). Biochem Biophys Res Commun. 1987;142:454
- Elevation of lymphocyte and hematopoietic stem cell numbers in mice transgenic for human granulocyte CSF. Lab Invest. 1996;74:384
- Collection of peripheral blood hematopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony-stimulating factor. Blood. 1993;82:1410
- G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation (parameters affecting bone marrow engraftment). Bone Marrow Transplant. 1993;12:609
- Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest. 1993;91:1310
- Megakaryocytes produce the receptor for granulocyte colony-stimulating factor. Blood. 1995;85:3359
- Novel monoclonal antibody reactive with thrombin-sensitive 74-kDa glycoproteins present on platelets and megakaryocytes both from mouse and rat. Hybridoma. 1995;14:361
- . Overexpression of granulocyte colony-stimulating factor in vivo decreases the level of polyploidization of mouse bone marrow megakaryocytes. Stem Cells. 1996;14:124
- Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood. 1995;85:2482
- Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α. J Immunol. 1992;149:918
- . Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood. 1995;86:4422
- Inhibition of resistance to hemopoietic allo-grafts in granulocyte colony-stimulating factor transgenic mice. Eur J Immunol. 1996;26:115
- Host F1 mice pretreated with granulocyte colony-stimulating factor accept parental bone marrow grafts in hybrid resistance system. Blood. 1997;89:1446
- . Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood. 1997;89:1629
- Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma (potential advantage of blood over marrow allografts). Blood. 1995;85:1659
- Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells. 1996;14:90
- Peripheral blood stem cell transplantation from unrelated donors (a comparison with marrow transplantation). Blood. 1999;94:455
- . Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products (a mechanism for monocyte-mediated suppression of T-cell proliferation). Blood. 1998;92:215
- Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-γ. Blood. 2000;95:270
- Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells. Cancer Res. 1990;50:7198
- Characteristic expression of Hck in human B-cell precursors. Exp Hematol. 2000;28:55
- Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood. 1994;83:1486
- Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells. Exp Hematol. 2000;28:1260
- . Toll-like receptors (critical proteins linking innate and acquired immunity). Nat Immunol. 2001;2:675
- Administration of granulocyte colony-stimulating factor induces hyporesponsiveness to lipopolysaccharide and impairs antigen-presenting function of peripheral blood monocytes. Exp Hematol. 2001;29:1117
- . CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol. 1994;153:2642
- . Endotoxin signal transduction in macrophages. J Leukoc Biol. 1996;60:8
- . Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci U S A. 1996;93:2774
- . Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway. Mol Med. 1994;1:93
- . Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol. 1996;59:152
- . Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α (TNF-α) translation (glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK). Mol Cell Biol. 1997;17:6274
- Lipopolysaccharide-induced tumor necrosis factor α production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun. 1999;67:3824
- Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 1999;10:39
- . Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood. 1994;84:1760
- Granulocyte colony-stimulating factor rapidly activates a distinct STAT-like protein in normal myeloid cells. Blood. 1995;86:4409
- TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells. J Immunol. 1999;163:1742
- . A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal transducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. J Biol Chem. 2001;276:29490
-
Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease.
Regulatory role of donor CD. 1995;8+(T cells. J Immunol 155):2396
- Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol. 1995;155:585
- . Interleukin-4 inhibits the expression of tumour necrosis factors α and β, interleukins-1 β and -6 and interferon-γ. Immunol Cell Biol. 1995;73:57
- G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplant. 2000;25:1035
- Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-α production. Blood. 1995;86:2220
- Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood. 2000;95:2269
PII: S0301-472X(02)00889-5
© 2002 International Society for Experimental Hematology. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Experimental Hematology
Volume 30, Issue 10
, Pages 1115-1123
, October 2002
